Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-18
DOI
10.3389/fneur.2018.00349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1
- (2018) Christina Wei et al. FASEB JOURNAL
- A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I
- (2017) Fan Zhang et al. HUMAN MOLECULAR GENETICS
- Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I
- (2016) Ruben Herrendorff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy
- (2016) Stacey D. Wagner et al. PLoS Genetics
- Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
- (2016) Guiying Chen et al. Scientific Reports
- Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics
- (2015) Anthony Chau et al. DEVELOPMENTAL DYNAMICS
- Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
- (2015) M. Chakraborty et al. Disease Models & Mechanisms
- Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models
- (2015) Ruth B. Siboni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models
- (2015) Ruth B. Siboni et al. Cell Reports
- In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
- (2015) Delphine Laustriat et al. Molecular Therapy-Nucleic Acids
- Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor
- (2014) Chun-Ho Wong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects
- (2014) Jason W. Hoskins et al. NUCLEIC ACIDS RESEARCH
- DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1
- (2014) O. J. Pettersson et al. NUCLEIC ACIDS RESEARCH
- Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
- (2014) Marzena Wojciechowska et al. RNA Biology
- Reducing Levels of Toxic RNA with Small Molecules
- (2013) Leslie A. Coonrod et al. ACS Chemical Biology
- A Novel CUGexp·MBNL1 Inhibitor with Therapeutic Potential for Myotonic Dystrophy Type 1
- (2013) Amin Haghighat Jahromi et al. ACS Chemical Biology
- Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling
- (2013) B. J. Quinn et al. Cancer Prevention Research
- Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors
- (2013) Hamza Chettouh et al. CANCER RESEARCH
- High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines
- (2013) Ami Ketley et al. HUMAN MOLECULAR GENETICS
- MBNL1 42 and MBNL1 43 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
- (2013) A Botta et al. Cell Death & Disease
- Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
- (2013) Kosuke Oana et al. Scientific Reports
- Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
- (2013) Anchel González-Barriga et al. Molecular Therapy-Nucleic Acids
- Rationally Designed Small Molecules Targeting the RNA That Causes Myotonic Dystrophy Type 1 Are Potently Bioactive
- (2012) Jessica L. Childs-Disney et al. ACS Chemical Biology
- Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins
- (2012) Eric T. Wang et al. CELL
- RNA targeting by small molecules: Binding of protoberberine, benzophenanthridine and aristolochia alkaloids to various RNA structures
- (2012) Gopinatha Suresh Kumar JOURNAL OF BIOSCIENCES
- GSK3β mediates muscle pathology in myotonic dystrophy
- (2012) Karlie Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Design of a Bioactive Small Molecule That Targets the Myotonic Dystrophy Type 1 RNA via an RNA Motif–Ligand Database and Chemical Similarity Searching
- (2012) Raman Parkesh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- RNA Interference Targeting CUG Repeats in a Mouse Model of Myotonic Dystrophy
- (2012) Krzysztof Sobczak et al. MOLECULAR THERAPY
- Targeting nuclear RNA for in vivo correction of myotonic dystrophy
- (2012) Thurman M. Wheeler et al. NATURE
- RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1
- (2012) J. E. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of new inhibitors of protein kinase R guided by statistical modeling
- (2011) Ruslana Bryk et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Suppression of PKR Promotes Network Excitability and Enhanced Cognition by Interferon-γ-Mediated Disinhibition
- (2011) Ping Jun Zhu et al. CELL
- Expanded CUG Repeats Dysregulate RNA Splicing by Altering the Stoichiometry of the Muscleblind 1 Complex
- (2011) Sharan Paul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats
- (2011) E. Querido et al. JOURNAL OF CELL SCIENCE
- Interaction of β-Carboline Alkaloids with RNA
- (2010) Shohreh Nafisi et al. DNA AND CELL BIOLOGY
- Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
- (2010) Virginie François et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1
- (2010) Riccardo Perbellini et al. NEUROMUSCULAR DISORDERS
- Non-ATG-initiated translation directed by microsatellite expansions
- (2010) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
- (2009) Guey-Shin Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Rational Design of Ligands Targeting Triplet Repeating Transcripts That Cause RNA Dominant Disease: Application to Myotonic Muscular Dystrophy Type 1 and Spinocerebellar Ataxia Type 3
- (2009) Alexei Pushechnikov et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding
- (2009) J. F. Arambula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pentamidine reverses the splicing defects associated with myotonic dystrophy
- (2009) M. B. Warf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
- (2009) S. A. M. Mulders et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
- (2009) T. M. Wheeler et al. SCIENCE
- A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase
- (2008) Hsin-Mei Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation
- (2008) Tao Sun et al. NUCLEIC ACIDS RESEARCH
- Genetic and Chemical Modifiers of a CUG Toxicity Model in Drosophila
- (2008) Amparo Garcia-Lopez et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search